RELX logo

RELX PLC - SPON ADR

RELXNYSE
πŸ† #224 by market capEarnings Feb 18US Equity
$35.37β–Ό $0.25 (βˆ’0.70%)
Market closed Β· at close
1hβ€”
24hβ–Ό 0.7%
7dβ–Ό 3.4%
14dβ–Ό 7.5%
30dβ–² 5.9%
1yβ–Ό 26.0%
🏦Market Cap
$61.75B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+1.6%
Slowing
πŸ“ŠGross Margin
62.6%
High
πŸ’΅FCF Margin
29.9%
Strong
βš–οΈP/S Ratio
4.7x
Fair
Otter Score
61
Fair

Trading Snapshot

Day Range
$34.94 – $35.83
52-Week Range
$27.57 – $48.98
Volume
$1.95B
Avg Volume
$1.42B
Shares Outstanding
1.75B
Next Earnings
Oct 3, 2026

Fundamentals Snapshot

Annual Revenue
$9.59B
Last Q Revenue
$4.91B
P/E Ratio
20.7
P/S Ratio
4.7x
EPS (TTM)
$1.27
Dividend Yield
1.55%

Why Investors Own RELX

  • βœ“High-growth profile β€” revenue up +28.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 75% gross margin and 10% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$9.59Bβ–² +34.7% YoY
Gross Margin (TTM)
75.3%β–² +2.6% YoY
Operating Income (TTM)
$2.51Bβ–² +34.7% YoY
Free Cash Flow (TTM)
$969Mβ–² +34.7% YoY

About RELX PLC - SPON ADR

RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
61/100

Analyst Price Target

β“˜
Average Target
$39.28
β–² +11.1% Upside
High Target$48.01
Low Target$30.05
Based on 30 analysts

Latest News & Updates